Prasol Chemicals IPO is a book-built issue worth ₹500 crore, comprising a fresh issue of 11.83 lakh shares aggregating to ₹80 crore and an offer for sale of 62.13 lakh shares worth ₹420 crore. The IPO will open for subscription on September 8, 2026, and close on September 10, 2026. The allotment is expected to be finalised on September 11, while the shares are likely to be listed on NSE and BSE on September 16, 2026.
The company has fixed the price band at ₹643 to ₹676 per share, with a lot size of 22 shares. Retail investors need a minimum investment of ₹14,872 at the upper price band. DAM Capital Advisors Ltd. is the book-running lead manager, while Kfin Technologies Ltd. is the registrar. Investors can refer to the RHP for detailed information.
Company Overview
Established in 1992, Prasol Chemicals Ltd. has more than three decades of experience in the specialty chemicals industry. The company operates as a forward-integrated manufacturer, producing acetone-based, phosphorus-based and other specialty chemicals involving complex chemistries. As of July 15, 2026, its portfolio covered more than 150 specialty chemical products, serving over 1,600 customers across 69 countries.
Prasol’s products cater to a wide range of end-use industries, including performance chemicals, paints, inks, construction and adhesives, pharmaceuticals, agrochemicals, and home and personal care. Its portfolio includes 21 acetone-based products, 53 phosphorus-based products and 76 other specialty chemicals such as surfactants, performance additives, ethers, esters, polymers and acids.
The company has a global distribution network spanning 63 countries across APAC, North America, South America and Europe and is recognised as a 3 Star Export House. Its established customer relationships and extensive product range support its market position, while customer approval requirements and long development cycles create entry barriers. Prasol also focuses on R&D and has 40 products under development.
IPO Details
| Particulars | Details |
|---|---|
| IPO Date | 8 to 10 Sep, 2026 |
| Allotment | Fri, Sep 11, 2026 |
| Listing Date | Wed, Sep 16, 2026 |
| Face Value | ₹2 per share |
| Price Band | ₹643 to ₹676 per share |
| Lot Size | 22 Shares |
| Issue Type | Bookbuilding IPO |
| Sale Type | Fresh capital cum OFS |
| Total Issue Size | 73,96,437 shares (agg. up to ₹500 Cr) |
| Offer for Sale | 62,13,006 shares of ₹2 (agg. up to ₹420 Cr) |
| Fresh Issue | 11,83,431 shares (agg. up to ₹80 Cr) |
| Shareholding Pre-Issue | 5,80,00,000 shares |
| Shareholding Post-Issue | 5,91,83,431 shares |
| Listing Exchange | BSE, NSE |
(Compiled from RHP and market updates)
Industry Context
- Global chemicals demand has expanded steadily, supported by industrialisation and consumption across construction, automotive, agriculture, healthcare and consumer goods. The industry is projected to reach USD 7.8 trillion by CY29, despite periodic macroeconomic disruptions.
- Specialty chemicals represent a high-value segment focused on performance, quality and customised applications. The global market grew to USD 1,240 billion in CY25 and is expected to reach USD 1,748 billion by CY29.
- India’s specialty chemicals sector has grown from ₹2,240 billion in FY19 to ₹5,563 billion in FY26. It is projected to reach ₹7,541 billion by FY29, driven by domestic demand, exports, import substitution and diverse applications.
- Government initiatives are strengthening India’s chemical manufacturing ecosystem through 100% FDI under the automatic route, Bulk Drug Parks, PCPIRs and regulatory reforms. A proposed chemicals PLI scheme could further encourage domestic production, investments and exports.
- India is expected to be the fastest-growing major Asian specialty chemicals market during CY25–CY29, with projected growth of 10–12%. Supply-chain diversification away from China, foreign investments and domestic demand could further enhance its competitive position.
Business Strengths
- Prasol Chemicals benefits from a broad portfolio of over 150 specialty products serving more than 1,600 customers across diverse industries and 69 countries, reducing dependence on any single end-use market or geography.
- Strong R&D capabilities support product innovation, with 40 specialty chemicals under development. Dedicated facilities and pilot plants enable customised solutions, product testing and faster adaptation to evolving customer requirements across multiple applications.
- The company has built long-standing relationships with a diversified customer base, serving 1,618 customers in FY26. Its global distribution network across six continents strengthens market reach and reduces concentration risks.
- Prasol Chemicals holds 3 Star Export House status and has international registrations, including European REACH and K-REACH. Its Authorised Economic Operator certification further supports reliable cross-border operations and global supply-chain participation.
- A qualified leadership team with extensive specialty chemicals experience oversees strategy, R&D, manufacturing, international sales and finance. The company also has a succession framework designed to support leadership continuity and sustainable business growth.
Business Risks
- Dependence on two manufacturing facilities exposes Prasol Chemicals to operational disruptions from regulatory action, equipment failures, industrial accidents, adverse weather, natural calamities, labour issues and capacity under-utilisation, potentially affecting production and financial performance.
- Handling hazardous, corrosive and flammable raw materials, by-products and finished chemicals creates risks of leakages, fires, explosions and accidents, which could cause casualties, property damage, environmental liabilities, operational shutdowns and regulatory consequences.
- Outstanding legal proceedings involving the Company, Promoters and Directors create potential financial, operational and reputational risks, with adverse outcomes possibly resulting in liabilities, regulatory consequences and an adverse impact on the Company’s overall business performance.
- Fluctuations in net cash generated from operating activities may constrain Prasol Chemicals’ ability to fund operations and expansion. Sustained negative or volatile cash flows could weaken liquidity, financial flexibility, growth prospects and investor confidence.
- Prasol Chemicals’ performance depends partly on demand for customers’ end-products across sectors such as paints, inks, construction, adhesives, lubricants and mining. Weak customer demand could consequently reduce product demand, revenues and profitability.
Financial Performance
Prasol Chemicals Ltd. – Financials (₹ in Million)
| Particulars | Fiscal 2026 | Fiscal 2025 | Fiscal 2024 |
|---|---|---|---|
| Revenue from Operations | 12,325.93 | 10,124.94 | 8,765.65 |
| Operating EBITDA | 1,393.20 | 877.66 | 605.28 |
| Profit / (Loss) After Tax (PAT) | 831.24 | 435.69 | 181.31 |
| PAT Margin (%) | 6.74% | 4.30% | 2.07% |
| Return on Capital Employed (ROCE) (%) | 22.43% | 14.95% | 12.61% |
| Return on Net Worth (%) | 18.53% | 11.86% | 5.56% |
| Return on Equity (%) | 20.37% | 12.57% | 5.71% |
(Source: RHP)
Key Ratios & Metrics
| KPI (Mar 31, 2026) | Value |
|---|---|
| Return on Equity (ROE) | 20.37% |
| Return on Capital Employed (ROCE) | 22.43% |
| Debt-to-Equity Ratio | 0.19 |
| Return on Net Worth (RoNW) | 18.53% |
| PAT Margin | 6.74% |
| EBITDA Margin | 11.30% |
(Source: RHP)
Objects of the Offer
- ₹60 crore will be used to repay or prepay, fully or partly, selected borrowings, reducing the company’s debt burden.
- Remaining IPO proceeds will support general corporate purposes, providing flexibility for routine business and operational requirements.
Conclusion
Prasol Chemicals enters the IPO with an established presence in specialty chemicals, a diversified product portfolio and a growing international customer base. Its improving profitability is encouraging, with ROE and ROCE rising sharply in FY26, while the low debt-to-equity ratio indicates a relatively manageable leverage position. The broader growth outlook for India’s specialty chemicals industry also provides a supportive backdrop.
However, investors should weigh these positives against operational, regulatory, raw material and end-market risks, along with the large OFS component of the issue. Overall, Prasol Chemicals offers an interesting growth opportunity, but investors should carefully assess the IPO valuation and risk factors before making an investment decision.
Disclaimer: Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. This content is purely for informational purposes only and should not be considered as investment advice or a recommendation. Securities quoted are for illustration purposes only and not recommendatory. Investors are requested to do their own due diligence before investing.
Paytm Money Ltd. SEBI Reg. No. Broking – INZ000240532; Depository Participant – IN – DP – 416 – 2019, Depository Participant Number: CDSL – 12088800. Trading and clearing member of NSE (90165, M52073), BSE (6707), MCX (57525), NCDEX (1315, M51110), and MSEI (85300). SEBI Reg. No. Research Analyst – INH000020086. Regd. Office: 136, 1st Floor, Devika Tower, Nehru Place, Delhi – 110019. For complete Terms & Conditions and Disclaimers visit: https://www.paytmmoney.com/stocks/policies/terms
